Orserdu Evropska unija - danščina - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Suxamethonium chloride "Aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

suxamethonium chloride "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte

laboratoire aguettant - suxamethoniumchlorid (vandfrit) - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml

Indivina 5 mg + 1 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

indivina 5 mg + 1 mg tabletter

orion corporation - estradiolvalerat, medroxyprogesteronacetat - tabletter - 5 mg + 1 mg

Indivina 5 mg + 2 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

indivina 5 mg + 2 mg tabletter

orion corporation - estradiolvalerat, medroxyprogesteronacetat - tabletter - 5 mg + 2 mg

Divina tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

divina tabletter

paranova danmark a/s - estradiolvalerat, medroxyprogesteronacetat - tabletter